Your browser does not support iframes.
JERUSALEM--(BUSINESS WIRE)--May 8, 2015--
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio
webcast at the Bank of America Merrill Lynch 2015 Health Care
Conference. Eyal Desheh, Group EVP & CFO will present on Wednesday, May
13, 2015 at 3:40 PM PT.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) is a leading
global pharmaceutical company that delivers high-quality,
patient-centric healthcare solutions to millions of patients every day.
Headquartered in Israel, Teva is the world’s largest generic medicines
producer, leveraging its portfolio of more than 1,000 molecules to
produce a wide range of generic products in nearly every therapeutic
area. In specialty medicines, Teva has a world-leading position in
innovative treatments for disorders of the central nervous system,
including pain, as well as a strong portfolio of respiratory products.
Teva integrates its generics and specialty capabilities in its global
research and development division to create new ways of addressing unmet
patient needs by combining drug development capabilities with devices,
services and technologies. Teva's net revenues in 2014 amounted to $20.3
billion. For more information, visit www.tevapharm.com.
Source: Teva Pharmaceutical Industries Ltd.
IR Contacts:Kevin C. Mannix, (215) 591-8912United
StatesorRan Meir, (215) 591-3033United StatesorTomer
Amitai, 972 (3) 926-7656IsraelorPR Contacts:Iris
Beck Codner, 972 (3) 926-7246IsraelorDenise
Bradley, (215) 591-8974United States